Раздел 5.5

1. WHO Classification of Tumours Editorial Board. WHO Classification of Tumours. Soft tissue and bone tumours, 5th ed. Vol. 3. Lyon: IARC; 2020.
2. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Version 2.2024, 03/12/24. National Comprehensive Cancer Network (NCCN)
3. Валиев А.К., Тепляков В.В., Мусаев Э.Р., Рогожин Д.В., Сушенцов Е.А., Мачак Г.Н. и соавт. Практические рекомендации по лечению первичных злокачественных опухолей костей. Злокачественные опухоли : Практические рекомендации RUSSCO #3s2, 2022 (том 12). С. 307–329.
4. Amin M.B., Edge S.B., Greene F.L., et al. AJCC Cancer Staging Manual, 8th edition. New York: Springer; 2017.
5. Детская онкология. Национальное руководство. Под ред. М.Д. Алиева, В.Г. Полякова, Г.Л. Менткевича, С.А. Маяковой. М.: Издательская группа РОНЦ. Практическая медицина, 2012. 684 с.
6. Malawer M.M., Sugarbaker P.H. Musculoskeletal Cancer Surgery - Treatment of Sarcomas and Allied Diseases. Springer, 2001. 626 p.
7. Piero Picci, Marco Manfrini, Davide Maria Donati, Marco Gambarotti, Alberto Righi, Daniel Vanel, Angelo Paolo Dei Tos. (2020). Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions Clinical, Radiological and Histological Correlations - The Rizzoli Case Archive: Clinical, Radiological and Histological Correlations - The Rizzoli Case Archive. doi: 10.1007/978-3-030-29676-6Casali PG, Bielack S, Abecassis N, et al.. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct 1;29(Suppl 4):iv79-95. PMID:30285218
8. Casali P.G., Bielack S., Abecassis N., et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct 1;29(Suppl 4):iv79-95. PMID:30285218.
9. Bin Alamer O., Haider A.S., Haider M., Sagoo N.S., Robertson F.C., Arrey E.N., Aoun S.G., Yu K., Cohen-Gadol A.A., El Ahmadieh T.Y. Primary and radiation induced skull base osteosarcoma: a systematic review of clinical features and treatment outcomes. J Neurooncol. 2021 Jun;153(2):183-202. doi: 10.1007/s11060-021-03757-z. Epub 2021 May 17. PMID: 33999382; PMCID: PMC9312842.
10. Guo Z., Hu K., Zhao B., Bian E., Ni S., Wan J. Osteosarcoma of the skull base: An analysis of 19 cases and literature review. J Clin Neurosci. 2017 Oct;44:133-142. doi: 10.1016/j.jocn.2017.06.014. Epub 2017 Jun 27. PMID: 28666652.
11. Tal A.L., Doshi H., Parkar F., Abraham T., Love C., Ye K., et al. The Utility of 18FDG PET/CT Versus Bone Scan for Identi cation of Bone Metastases in a Pediatric Sarcoma Population and a Review of the Lit- erature. J Pediatr Hematol Oncol 2021; 43 (2): 52–8.
12. Bielack S., Jürgens H., Jundt G. et al. Osteosarcoma: the COSS experience. Cancer Treat Res 2009; 152: 289–308.
13. Whelan J.S., Bielack S.S., Marina N., et al. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment. Ann Oncol. 2015;26(2):407-414.
14. Carrle D., Bielack S. Osteosarcoma lung metastases detection and principles of multimodal therapy. Cancer Treat Res. 2009;152:165-84. doi: 10.1007/978-1-4419-0284-9_8. PMID: 20213390.
15. М.Я. Ядгаров, Е.Д. Киреева, Кайлаш, М.М. Дунайкин, Ю.Н. Ликарь. «Диагностическая роль ПЭТ/КТ с 18F-ФДГ и сцинтиграфии костей скелета у детей и молодых взрослых с костными саркомами: систематический обзор и метаанализ» // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2023;22(4):158-169 https://doi.org/10.24287/1726-1708-2023-22-4-158-169).
16. Kubo T. et al. A meta-analysis supports core needle biopsy by radiologists for better histological diagnosis in soft tissue and bone sarcomas // Medicine (United States). Lippincott Williams and Wilkins, 2018. Vol. 97, № 29. P. e11567.
17. Pohlig F. et al. Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a retrospective study. // Eur. J. Med. Res. 2012. Vol. 17. P. 29.
18. Mankin H.J., Mankin C.J., Simon M.A. The hazards of the biopsy, revisited: For the members of the musculoskeletal tumor society // J. Bone Jt. Surg. - Ser. A. 1996. Vol. 78, № 5. P. 656–663.
19. Clark C.R. et al. The effect of biopsy-hole shape and size on bone strength. // J. Bone Joint Surg. Am. 1977. Vol. 59, № 2. P. 213–217.
20. Traina F. et al. Current concepts in the biopsy of musculoskeletal tumors: AAOS exhibit selection // J. Bone Jt. Surg. - Am. Vol. Journal of Bone and Joint Surgery Inc., 2015. Vol. 97, № 2. P.e7(1).
21. Мацко Д.Е. Саркомы костей: классификация, гистологическое строение, особенности морфологической диагностики // Практическая онкология. 2010. Vol. 11, № 1. С. 1–10.
22. Pohlig F. et al. Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a retrospective study. // Eur. J. Med. Res. 2012. Vol. 17. P. 29.
23. Peled Y., Levin D., Shiran S., Manisterski M., Shukrun R., Elhasid R. Prevalence and management of methotrexate-induced neurotoxicity in pediatric patients with osteosarcoma: a single-center experience. Int J Clin Oncol. 2022 Aug;27(8):1372-1378. doi: 10.1007/s10147-022-02184-y. Epub 2022 May 31. PMID: 35639227.
24. Lien H.H., Blomlie V., Saeter G., Solheim O., Fosså S.D. Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate. Radiology. 1991 May;179(2):547-50. doi: 10.1148/radiology.179.2.2014309. PMID: 2014309.
25. Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol. 2008 Jan;19(1):178-84. doi: 10.1093/annonc/mdm466. Epub 2007 Oct 17. PMID: 17947226.
26. Grimer R., Athanasou N., Gerrand C., et al. UK guidelines for the management of bone sarcomas. Sarcoma. 2010;2010:317462. PMID:21253474